The CLIO Consortium: Optimization of Cerenkov Luminescence Imaging for Image-Guided Cancer Surgery
Cancer is the second largest cause of death and morbidity in Europe, with more than 3 million new cases diagnosed each year. The most effective treatment strategy for most forms of cancer is early detection followed by surgery. 

euflag rea flag cli logo3

The CLI Project aims to evaluate the imaging technology in patients undergoing surgery for gastric cancer.


The Project has led to production of prototype imaging devices, the pre-clinical trials of those and a proof-of-concept clinical trial at the 1st Department of Surgery, Medical Faculty of Semmelweis University Budapest, Hungary. An in-vitro diagnostic medical device has received the CE Mark and is currently marketed by Lightpoint Medical in the EU as a fully authorized system to detect excised tumour margin status.

The Consortium acknowledges the FP7 Grant in obtaining novel results in image-guided surgery.
The Project is European Union funded research Programme under the Seventh Framework Programme (FP7). FP7 has been the EU's main instrument for supporting innovative research in Europe, and has had two main strategic objectives: to strengthen the scientific and technological base of European industry and to encourage its international competitiveness, while promoting research that has supported EU policies. For more information visit


Grant Agreement No: 606614